openPR Logo
Press release

Stem Cell Assays Market to Expand at a CAGR of 16.5% during Forecast Period 2023-2033, as per TMR Study

03-06-2024 09:13 AM CET | Health & Medicine

Press release from: Transparency Market Research

Stem Cell Assays

Stem Cell Assays

The globalย ๐’๐ญ๐ž๐ฆ ๐‚๐ž๐ฅ๐ฅ ๐€๐ฌ๐ฌ๐š๐ฒ๐ฌ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ was valuedย atย US$ 1.6 Billion in 2022.ย Withย 16.5%ย projectedย growthย from 2023 to 2033, the market is expected to reach a valuation ofย US$ 8.5 Billionย by the end of the forecast period.

๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐…:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19364&utm_source=OpenPR&utm_campaign=MansiR

๐–๐ก๐š๐ญ ๐š๐ซ๐ž ๐ญ๐ก๐ž ๐Š๐ž๐ฒ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐ˆ๐ง๐Ÿ๐ฅ๐ฎ๐ž๐ง๐œ๐ข๐ง๐  ๐’๐ญ๐ž๐ฆ ๐‚๐ž๐ฅ๐ฅ ๐€๐ฌ๐ฌ๐š๐ฒ๐ฌ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐„๐ฑ๐ฉ๐š๐ง๐ฌ๐ข๐จ๐ง?

The expansion of the market is significantly driven by escalating demands for regenerative medicines, advancements in stem cell research technology, the prevalence of chronic diseases, and augmented investment in research and development initiatives. Stem cell applications have broadened due to the emergence of new culture techniques like 3-D cell culture and organoids, necessitating innovative stem cell assays to enhance understanding of stem cell behavior. Stem cells possess the capacity to differentiate into various cell types, thus fueling the rising demand for stem cell-based therapies, particularly in regenerative medicine.

The surge in chronic diseases, including cancer, diabetes, Alzheimer's, Parkinson's disease, and multiple myeloma, has heightened the preference for stem cell therapy in drug discovery, diagnosis, and treatment strategies, leveraging their self-renewable capabilities. Notably, in the United States, the prevalence of diabetes has reached alarming levels, with millions diagnosed annually, driving the demand for stem cell assays to support treatment endeavors. Similarly, with multiple myeloma emerging as one of the most prevalent hematological cancers globally, the potential of stem cell transplant as a treatment avenue is expected to fuel the demand for stem cell assays in the coming years.

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

Thermo Fischer Scientific, Inc., Merck KGaA, Danaher Corporation, Becton, Dickinson, and Company, Bio-Rad Laboratories, PerkinElmer, Agilent Technologies, Promega Corporation, Cell Biolabs, Bio-Techne Corporation, FUJIFILM Holdings Corporation, Charles River Laboratories, Lonza Group, HemoGenix Inc., and Abcam Plc.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐๐ฒ ๐“๐ฒ๐ฉ๐ž:

Viability/Cytotoxicity Assays
Tetrazolium Reduction Assays
Resazurium Cell Viability Assay
Calcein-AM Cell Viability Assay
Other Viability/Cytotoxicity Assays
Isolation & Purification Assays
Cell Identification Assays
Proliferation Assays
Differentiation Assays
Function Assays
Apoptosis Assays
Caspase Assays
Annexin V and Cell Permeability Assays
DNA Fragmentation Assays
Mitochondrial Assays

๐๐ฒ ๐‚๐ž๐ฅ๐ฅ ๐“๐ฒ๐ฉ๐ž:

Adult Stem Cells
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Hematopoietic Stem Cells
Umbilical Cord Stem Cells
Neural Stem Cells
Human Embryonic Stem Cells

๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ & ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž:

Instruments
Flow Cytometers
Microelectrode Arrays
Cell Imaging & Analysis Systems
Automated Cell Counters
Kits
Services

๐๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง:

Regenerative Medicine & Therapy Development
Orthopedic, Musculoskeletal, and Spine Applications
Dermatology
Cardiovascular
CNS
Oncology
Diabetes
Other Regenerative Medicine & Therapy Development
Drug Discovery and Development
Clinical Research

๐๐ฒ ๐„๐ง๐ ๐”๐ฌ๐ž๐ซ:

Academic & Research Institutes
Biopharmaceutical & Biotechnology Companies

๐†๐ž๐ญ ๐“๐ก๐ข๐ฌ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ, ๐ˆ๐ง๐ฌ๐ญ๐š๐ง๐ญ๐ฅ๐ฒ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=19364<ype=S&utm_source=OpenPR&utm_campaign=MansiR

๐‘๐ž๐ ๐ข๐จ๐ง๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ž๐:

North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ:

Emerging trends in the stem cell assays market include the integration of automation and artificial intelligence (AI) technologies to streamline assay workflows, the emergence of organoid-based assays for disease modeling, and the growing adoption of microfluidic platforms for high-throughput screening.

๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:

The future of the stem cell assays market appears promising, with continued research endeavors driving innovation and expanding the scope of applications. Moreover, collaborations between industry stakeholders, academic institutions, and regulatory bodies are expected to facilitate the translation of stem cell research into clinical practice.

๐Š๐ž๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐ฎ๐๐ฒ ๐๐จ๐ข๐ง๐ญ๐ฌ:

Analysis of market dynamics, including drivers, challenges, and trends
Assessment of market segmentation based on service type, sourcing type, application, industry vertical, and region
Evaluation of regional market dynamics and growth opportunities
Identification of key market players, their strategies, and recent developments
Future outlook and growth prospects in the stem cell assays market

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐Œ๐จ๐ซ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐“๐Œ๐‘:

๐‰๐ž๐ญ ๐‡๐š๐ง๐ ๐ƒ๐ซ๐ฒ๐ž๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2023/04/19/2650042/0/en/Jet-Hand-Dryer-Market-to-Grow-at-a-CAGR-of-9-9-from-2021-to-2031-Reaching-US-1-0-billion-As-per-TMR-Study.html

๐„๐ง๐ ๐ข๐ง๐ž๐ž๐ซ๐ž๐ ๐‚๐ž๐ฆ๐ž๐ง๐ญ๐ข๐ญ๐ข๐จ๐ฎ๐ฌ ๐‚๐จ๐ฆ๐ฉ๐จ๐ฌ๐ข๐ญ๐ž (๐„๐‚๐‚) ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2023/04/20/2651645/0/en/Engineered-Cementitious-Composite-ECC-Market-to-Reach-US-3-2-Bn-by-2031-TMR-Study.html

๐€๐›๐จ๐ฎ๐ญ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Transparency Market Research, a globalย market research companyย registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website:ย https://www.transparencymarketresearch.comย ย ย ย  ย ย 
Email:ย sales@transparencymarketresearch.com
Follow Us:ย LinkedIn|ย Twitter|ย Blogย |ย YouTube

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stem Cell Assays Market to Expand at a CAGR of 16.5% during Forecast Period 2023-2033, as per TMR Study here

News-ID: 3414262 • Views: โ€ฆ

More Releases from Transparency Market Research

Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion by 2036, Driven by Rising Opioid Use and Targeted Therapies
Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion โ€ฆ
The global opioid induced constipation (OIC) treatment market is witnessing steady and sustained growth as healthcare systems worldwide place increasing emphasis on comprehensive pain management and supportive care. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Growth is primarily fueled by the rising prevalence of chronicโ€ฆ
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product Type / By Impact Frequency | China โ€ข India โ€ข Japan โ€ข U.S.
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product T โ€ฆ
The global Pneumatic Flux Chipper Market is set to witness sustained and resilient growth over the next decade, underpinned by expanding heavy manufacturing activities, rising welding and fabrication demand, and continuous investments in industrial infrastructure across emerging and developed economies. According to the latest industry analysis, the market was valued at US$ 760.5 Mn in 2025 and is projected to reach US$ 1,680.8 Mn by 2036, expanding at a compoundโ€ฆ
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Billion in 2025 to US$ 244.4 Billion at 27% CAGR
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Bil โ€ฆ
The AI in automotive market is entering a phase of exponential expansion, supported by rapid digitization of vehicles, growing safety mandates, and consumer demand for intelligent mobility. The global market was valued at US$ 19.8 Bn in 2025 and is projected to reach US$ 244.4 Bn by 2036, registering a remarkable CAGR of 27% from 2026 to 2036. This growth trajectory reflects the transition of automobiles from mechanically driven products toโ€ฆ
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable Drug Demand
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable โ€ฆ
The global hypodermic needles market was valued at approximately US$ 4.2 billion in 2025 and is projected to reach around US$ 7.9 billion by 2036, expanding at a CAGR of nearly 5.8% from 2026 to 2036, driven by the rising prevalence of diabetes, cancer, and chronic diseases, growing demand for injectable drugs and biologics, and the expansion of global vaccination and immunization programs; increasing adoption of safety-engineered and disposable needles,โ€ฆ

All 5 Releases


More Releases for Assay

ProBio offers ADCC assay (SC1544) and CDC assay (SC1545) services for customers
ADCC & CDC assays Endpoint-Based, and Speedy Dramatic improvement of ADCC [https://www.probiocdmo.com/add-adcc-cdc-assay.html] by using recombinant NK cells Antibody therapy has been proven to be highly powerful for cancer treatment. Two important mechanisms used by antibody drugs to kill targeted tumor cells are Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), and Complement Dependent Cytotoxicity (CDC). ProBio is pleased to present to customers both a PBMC-based ADCC assay [https://www.probiocdmo.com/add-adcc-cdc-assay.html] and natural kill cell-based ADCC assay. The readout isโ€ฆ
Immunofluorescence Assay Market Report 2024 - Immunofluorescence Assay Market Si โ€ฆ
"The Business Research Company recently released a comprehensive report on the Global Immunofluorescence Assay Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sampleโ€ฆ
ELISpot and FluoroSpot Assay Market Combating Chronic and Infectious Diseases: T โ€ฆ
ELISpot and FluoroSpot Assay Market worth $512.39 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global ELISpot and FluoroSpot Assay Market- (By Product (Assay Kits (Assay Kits by Technique(ELISpot Assay Kits, FluroSpot Assay Kits), Assay Kits by Utility (Diagnostic Kits, Research Kits), Assay Kits by Analyte (T-cell-based kits, B-cell-based kits, Other analytic kits), Analyzers,โ€ฆ
Creatinine Assay Kits Market
The global creatinine assay kits market is expected to reach USD 285.86 Million by 2025, from USD 192.07 Million in 2017 growing at a CAGR of 5.1% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-creatinine-assay-kits-market Some of theโ€ฆ
Lateral Flow Assay Market
Worldwide Lateral Flow Assay Market Analysis to 2027 is a specialized and in-depth study of the Lateral Flow Assay industry with a focus on the global market trend. The report aims to provide an overview of global Lateral Flow Assay market with detailed market segmentation by product & services /application and geography. Get Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00005544/?utm_source=OpenPR&utm_medium=Sumaiya Lateral flow tests, also known as lateral flow immunochromatographic assays. The lateral flow assayโ€ฆ
ELISA Assay Dispensing Trends 2016
ReportsWorldwide has announced the addition of a new report ELISA Assay Dispensing Trends 2016 to its growing collection of premium market research reports. This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on enzyme-linked immunosorbent assays (ELISA) carried out in April 2016. The survey was initiated by HTStec as part of its tracking of life science marketplaces and to update HTStec's previous ELISA Assay Trends report (June 2012).โ€ฆ